Quarterly Results
2013
![]() |
OncoGenex First Quarter 2013 Conference Call | |
![]() |
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013 | |
![]() |
Form 10-Q | |
2012
![]() |
OncoGenex Third Quarter 2012 Conference Call | |
![]() |
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012 | |
![]() |
Form 10-Q | |
![]() |
OncoGenex First Quarter 2012 Conference Call | |
![]() |
OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development Highlights for First Quarter of 2012 | |
![]() |
Form 10-Q | |
2011
![]() |
OncoGenex Pharmaceuticals Reports Financial Results for Third Quarter 2011 and Highlights Advancement of Portfolio Compounds | |
![]() |
Form 10-Q | |
![]() |
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2011 and Provides Update on Development Activities | |
![]() |
Form 10-Q | |
![]() |
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2011 and Provides Update on Plans for the Phase 3 Prostate Cancer SATURN Clinical Trial | |
![]() |
Form 10-Q | |
2010
![]() |
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2010 and Provides Update on Custirsen Clinical Development Program | |
![]() |
Form 10-K | |
2009
![]() |
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Provides Outlook for 2010 | |
![]() |
Form 10-K | |
2008
![]() |
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 | |
![]() |
Form 10-K | |
2007
![]() |
Sonus Pharmaceuticals Highlights Corporate Progress and Reports Second Quarter Financial Results | |
![]() |
Form 10-Q | |
2006
![]() |
Sonus Pharmaceuticals Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial Results | |
![]() |
Form 10-K | |
![]() |
Sonus Pharmaceuticals Updates Corporate Progress and Reports Third Quarter Financial Results | |
![]() |
Form 10-Q | |
![]() |
Sonus Pharmaceuticals Updates Corporate Progress and Reports Second Quarter Financial Results | |
![]() |
Form 10-Q | |
2005
![]() |
Sonus Pharmaceuticals Highlights 2005 Progress and Reports Fourth Quarter and Full Year Financial Results | |
![]() |
Form 10-K | |
![]() |
Sonus Pharmaceuticals Highlights Corporate Progress and Reports Third Quarter Financial Results | |
![]() |
Form 10-Q | |
= add file to Briefcase
About OncoGeneX
For Patients
For Physicians
For Investors
Careers With Us
Investors
SHAREHOLDER TOOLS

© 2004-2011 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.
About OncoGenex
OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
For Patients
OncoGenex is uniquely focused on the challenge of cancer treatment resistance. We currently have several on-going clinical trials that may be of interest to you.
For Physicians
OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.







